Stocks Health care CELZ

NASDAQ · Health care

Creative Medical Technology Holdings, Inc. (CELZ)

Creative Medical Technology Holdings, Inc. brought in $3K of revenue over the twelve months to June 30, 2026, down 50.0% from a year earlier. It posted a net loss of $6M. At June 30, 2026 it held $8.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.

What Creative Medical Technology Holdings, Inc. does

Creative Medical Technology Holdings, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CELZ.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where CELZ ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Creative Medical Technology Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 25, 2026
   Material agreement 8-K
2. August 31, 2026
   Bylaws or fiscal year changed 8-K
3. August 7, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.41 versus -$0.48.
4. August 3, 2026
   Securities offering prospectus 424B3
5. July 24, 2026
   Shelf registration to sell securities S-3
6. July 14, 2026
   Proxy statement DEF 14A
7. July 2, 2026
   Executive or director change 8-K
8. July 1, 2026
   Preliminary proxy statement PRE 14A
9. June 30, 2026
   Form RW filing RW
10. June 26, 2026
    IPO registration (amended) S-1/A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 25, 2026. Insider transactions on SEC

Insider trades

What the people running Creative Medical Technology Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CELZ

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 1,034,904 shares in total, about $1.1M at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CELZ

What does Creative Medical Technology Holdings, Inc. do?

Creative Medical Technology Holdings, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker CELZ.

Is Creative Medical Technology Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $6M on revenue of $3K.

How much revenue does Creative Medical Technology Holdings, Inc. make?

Over the twelve months to June 30, 2026 Creative Medical Technology Holdings, Inc. reported revenue of $3K. That is 50.0% less than a year earlier.

When did Creative Medical Technology Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from September 25, 2026.

Similar companies

Compare CELZ with

Compare CELZ with any company

Follow CELZ

Get an email when Creative Medical Technology Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow CELZ: get an email when it files

Where the numbers come from

Financial figures are the values Creative Medical Technology Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.